- On a day when US stock markets are seeing outsized gains, upside for Invitae ( NYSE: NVTA ) and Pacific Biosciences of California ( NASDAQ: PACB ) is among the highest in the biomedical space as they are up, respectively, 39% and 21% in Thursday afternoon trading.
- As of 205p ET, ~23.7M Invitae shares had traded hands. Daily average volume is ~14.9M. For PacBio ( PACB ), the figure is ~7.4M shares. Daily average volume is ~7.7M.
- Despite Wednesday's gains, Invitae ( NVTA ) is down ~80% year to date, while PacBio ( PACB ) is down ~52% .
- Read why Seeking Alpha contributor Stella Mwende rates PacBio ( PACB ) a hold.
For further details see:
Invitae, Pacific Biosciences up, respectively, 39% and 21% as markets surge